Menon has over 41 years of diverse experience in some of the premier multinational and Indian companies in the chemical and power industry
The voluntary program is the first time the FDA will allow excipient manufacturers to obtain review of certain novel excipients prior to their use in drug formulations.
He has over 23 years' experience working in leading companies such as Omniactive Health Technologies, Johnson Matthey Chemicals, BASF, Godrej Agrovet Limited & Bharat Petroleum Corporation Limited.
Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today
The company has posted net profit of Rs. 13.21 crores for the period ended September 30, 2022
The JUMP-CP Consortium’s aim is to validate and scale up image-based drug discovery strategies by creating the world’s largest public cell imaging data set
It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
The company has reported total income of Rs. 3109.77 crores during the period ended September 30, 2022
Results reinforce commitment to next-generation oral SERD development programme
Submission based on QuANTUM-First results showing quizartinib plus chemotherapy significantly improved overall survival compared to chemotherapy alone
Subscribe To Our Newsletter & Stay Updated
